Rank | Gene Set | Z-score |
---|---|---|
1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.63555406 |
2 | maintenance of protein location in nucleus (GO:0051457) | 6.70393015 |
3 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.11263151 |
4 | interferon-gamma production (GO:0032609) | 6.10345157 |
5 | somite rostral/caudal axis specification (GO:0032525) | 5.06933066 |
6 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.91122959 |
7 | cytidine deamination (GO:0009972) | 4.55941559 |
8 | cytidine metabolic process (GO:0046087) | 4.55941559 |
9 | cytidine catabolic process (GO:0006216) | 4.55941559 |
10 | nucleoside transmembrane transport (GO:1901642) | 4.52260341 |
11 | regulation of cilium movement (GO:0003352) | 4.46357431 |
12 | response to dietary excess (GO:0002021) | 4.40327024 |
13 | negative regulation of telomerase activity (GO:0051974) | 4.24950419 |
14 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.24848094 |
15 | regulation of response to osmotic stress (GO:0047484) | 4.21703393 |
16 | tachykinin receptor signaling pathway (GO:0007217) | 4.10636523 |
17 | mitochondrion distribution (GO:0048311) | 4.07085391 |
18 | mannose metabolic process (GO:0006013) | 4.04146320 |
19 | histone H4-K5 acetylation (GO:0043981) | 4.02577294 |
20 | histone H4-K8 acetylation (GO:0043982) | 4.02577294 |
21 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.99855774 |
22 | muscle organ morphogenesis (GO:0048644) | 3.96902448 |
23 | negative regulation of cell size (GO:0045792) | 3.94610907 |
24 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.94439232 |
25 | negative regulation of telomere maintenance (GO:0032205) | 3.91750794 |
26 | histone H4-K12 acetylation (GO:0043983) | 3.81502018 |
27 | regulation of ARF protein signal transduction (GO:0032012) | 3.81055267 |
28 | NADH metabolic process (GO:0006734) | 3.78147548 |
29 | negative regulation of epidermis development (GO:0045683) | 3.75969574 |
30 | hormone catabolic process (GO:0042447) | 3.72550795 |
31 | coenzyme catabolic process (GO:0009109) | 3.72288252 |
32 | thymic T cell selection (GO:0045061) | 3.65153559 |
33 | maintenance of protein localization in organelle (GO:0072595) | 3.60215726 |
34 | response to pheromone (GO:0019236) | 3.59887850 |
35 | regulation of ARF GTPase activity (GO:0032312) | 3.59691346 |
36 | activation of MAPKKK activity (GO:0000185) | 3.58211329 |
37 | nucleoside transport (GO:0015858) | 3.55338851 |
38 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.50629765 |
39 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.50214239 |
40 | synaptic vesicle exocytosis (GO:0016079) | 3.49424721 |
41 | retinal rod cell development (GO:0046548) | 3.48205008 |
42 | phenol-containing compound catabolic process (GO:0019336) | 3.46710440 |
43 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.46595606 |
44 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.44085709 |
45 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.42656765 |
46 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.36207617 |
47 | primitive streak formation (GO:0090009) | 3.32865267 |
48 | histone H4-K16 acetylation (GO:0043984) | 3.32436480 |
49 | negative regulation of interleukin-2 production (GO:0032703) | 3.32188791 |
50 | adaptation of signaling pathway (GO:0023058) | 3.31054283 |
51 | histone H3-K4 methylation (GO:0051568) | 3.26858388 |
52 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.26351092 |
53 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.26034397 |
54 | Peyers patch development (GO:0048541) | 3.26034397 |
55 | quinone metabolic process (GO:1901661) | 3.25984288 |
56 | histone H3-K4 trimethylation (GO:0080182) | 3.25180579 |
57 | positive regulation of histone deacetylation (GO:0031065) | 3.25079817 |
58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.25020727 |
59 | protein kinase C signaling (GO:0070528) | 3.24832992 |
60 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.23197691 |
61 | positive regulation of protein deacetylation (GO:0090312) | 3.22465822 |
62 | positive regulation of synapse maturation (GO:0090129) | 3.21362820 |
63 | regulation of telomere maintenance (GO:0032204) | 3.21079991 |
64 | histone H4 deacetylation (GO:0070933) | 3.19875308 |
65 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.19511446 |
66 | negative regulation of viral release from host cell (GO:1902187) | 3.19016700 |
67 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.18074864 |
68 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.16641349 |
69 | retinoic acid receptor signaling pathway (GO:0048384) | 3.13940425 |
70 | T cell selection (GO:0045058) | 3.11543773 |
71 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.11410002 |
72 | establishment of endothelial barrier (GO:0061028) | 3.05845540 |
73 | proline biosynthetic process (GO:0006561) | 3.04270832 |
74 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 3.03902625 |
75 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.01966255 |
76 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.00426421 |
77 | histone H3 deacetylation (GO:0070932) | 2.97946660 |
78 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.97635563 |
79 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.96850943 |
80 | creatine metabolic process (GO:0006600) | 2.96077352 |
81 | signal complex assembly (GO:0007172) | 2.95262466 |
82 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.94895257 |
83 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.93952058 |
84 | positive regulation of Rap GTPase activity (GO:0032854) | 2.93141203 |
85 | glutamate secretion (GO:0014047) | 2.92354143 |
86 | regulation of cholesterol metabolic process (GO:0090181) | 2.89060973 |
87 | phosphatidylinositol 3-kinase signaling (GO:0014065) | 2.88044310 |
88 | positive T cell selection (GO:0043368) | 2.87464892 |
89 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85650065 |
90 | nonmotile primary cilium assembly (GO:0035058) | 2.85265326 |
91 | rRNA transcription (GO:0009303) | 2.85028834 |
92 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.83486165 |
93 | negative regulation of cell killing (GO:0031342) | 2.83486165 |
94 | regulation of chromatin binding (GO:0035561) | 2.82466525 |
95 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.82023330 |
96 | synaptic vesicle maturation (GO:0016188) | 2.80790427 |
97 | cellular modified amino acid catabolic process (GO:0042219) | 2.80351571 |
98 | negative regulation of bone resorption (GO:0045779) | 2.79340082 |
99 | positive regulation of odontogenesis (GO:0042482) | 2.79182722 |
100 | icosanoid secretion (GO:0032309) | 2.77684068 |
101 | arachidonic acid secretion (GO:0050482) | 2.77684068 |
102 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76867860 |
103 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76145027 |
104 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76055310 |
105 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.76021370 |
106 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.75997479 |
107 | detection of temperature stimulus (GO:0016048) | 2.75323202 |
108 | activation of Rac GTPase activity (GO:0032863) | 2.75067276 |
109 | T cell differentiation involved in immune response (GO:0002292) | 2.73763372 |
110 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.73763372 |
111 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.73763372 |
112 | positive regulation of defense response to virus by host (GO:0002230) | 2.73096689 |
113 | regulation of Rap GTPase activity (GO:0032317) | 2.72030755 |
114 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.71465279 |
115 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.71208371 |
116 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.70931477 |
117 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.69665233 |
118 | negative thymic T cell selection (GO:0045060) | 2.69128237 |
119 | sodium ion export (GO:0071436) | 2.69113319 |
120 | proline transport (GO:0015824) | 2.66914184 |
121 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.66448126 |
122 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.66353130 |
123 | regulation of alkaline phosphatase activity (GO:0010692) | 2.65675319 |
124 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.64088759 |
125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.64088759 |
126 | regulation of microtubule-based movement (GO:0060632) | 2.64066644 |
127 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.63580843 |
128 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.63236676 |
129 | rRNA methylation (GO:0031167) | 2.62779381 |
130 | response to muramyl dipeptide (GO:0032495) | 2.61358961 |
131 | negative T cell selection (GO:0043383) | 2.61197856 |
132 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.60627176 |
133 | detection of bacterium (GO:0016045) | 2.60347998 |
134 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.60090760 |
135 | negative regulation of granulocyte differentiation (GO:0030853) | 2.59977157 |
136 | activation of JUN kinase activity (GO:0007257) | 2.59813464 |
137 | cell proliferation involved in metanephros development (GO:0072203) | 2.59212813 |
138 | positive regulation of B cell differentiation (GO:0045579) | 2.58506631 |
139 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.58080993 |
140 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.57767384 |
141 | transepithelial transport (GO:0070633) | 2.57161063 |
142 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.56125223 |
143 | mitochondrion transport along microtubule (GO:0047497) | 2.56125223 |
144 | establishment of mitochondrion localization (GO:0051654) | 2.54686087 |
145 | glycolipid biosynthetic process (GO:0009247) | 2.54117459 |
146 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.53822273 |
147 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.53278360 |
148 | leukocyte aggregation (GO:0070486) | 2.51270618 |
149 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.50958415 |
150 | regulation of respiratory burst (GO:0060263) | 2.50155048 |
151 | actin filament polymerization (GO:0030041) | 2.50024379 |
152 | regulation of necrotic cell death (GO:0010939) | 2.48999642 |
153 | natural killer cell activation (GO:0030101) | 2.48893660 |
154 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.48467169 |
155 | positive thymic T cell selection (GO:0045059) | 2.48442020 |
156 | regulation of synapse maturation (GO:0090128) | 2.46135260 |
157 | regulation of monocyte differentiation (GO:0045655) | 2.44542004 |
158 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.44322903 |
159 | tricarboxylic acid metabolic process (GO:0072350) | 2.44285980 |
160 | positive regulation of tissue remodeling (GO:0034105) | 2.43686797 |
161 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.43400032 |
162 | regulation of leukocyte degranulation (GO:0043300) | 2.43239219 |
163 | proline metabolic process (GO:0006560) | 2.42338915 |
164 | mammary gland alveolus development (GO:0060749) | 2.41952813 |
165 | neurotransmitter secretion (GO:0007269) | 2.41605642 |
166 | UV protection (GO:0009650) | 2.41218812 |
167 | hypotonic response (GO:0006971) | 2.41142938 |
168 | regulation of regulated secretory pathway (GO:1903305) | 2.39641942 |
169 | regulation of mast cell degranulation (GO:0043304) | 2.39379216 |
170 | cell migration in hindbrain (GO:0021535) | 2.39336083 |
171 | regulation of female receptivity (GO:0045924) | 2.39149523 |
172 | negative regulation of myotube differentiation (GO:0010832) | 2.36743770 |
173 | apoptotic process involved in morphogenesis (GO:0060561) | 2.35981105 |
174 | regulation of interleukin-4 production (GO:0032673) | 2.34555191 |
175 | neuronal ion channel clustering (GO:0045161) | 2.32717353 |
176 | cell volume homeostasis (GO:0006884) | 2.32621978 |
177 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.32532567 |
178 | female mating behavior (GO:0060180) | 2.32325753 |
179 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.31947908 |
180 | negative regulation of necroptotic process (GO:0060546) | 2.31576404 |
181 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.31532336 |
182 | 2-oxoglutarate metabolic process (GO:0006103) | 2.30632135 |
183 | mature B cell differentiation involved in immune response (GO:0002313) | 2.29988161 |
184 | detection of other organism (GO:0098543) | 2.28377182 |
185 | retrograde transport, endosome to Golgi (GO:0042147) | 2.28281677 |
186 | oxaloacetate metabolic process (GO:0006107) | 2.27959069 |
187 | germinal center formation (GO:0002467) | 2.27612131 |
188 | polyketide metabolic process (GO:0030638) | 11.8590102 |
189 | doxorubicin metabolic process (GO:0044598) | 11.8590102 |
190 | daunorubicin metabolic process (GO:0044597) | 11.8590102 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.41572885 |
2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.91965716 |
3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.91965716 |
4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.91965716 |
5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.22745655 |
6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.99091917 |
7 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.52083434 |
8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.44100495 |
9 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.35094965 |
10 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.27995478 |
11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18042245 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.16299919 |
13 | P68_20966046_ChIP-Seq_HELA_Human | 2.12751589 |
14 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.12342181 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.12057070 |
16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.10248466 |
17 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.09999004 |
18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.08680609 |
19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.04387588 |
20 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.02619362 |
21 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.00865488 |
22 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.98712673 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.92179258 |
24 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.91689955 |
25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.87289214 |
26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81280692 |
27 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.80418797 |
28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79420523 |
29 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.79035137 |
30 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.78432517 |
31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78380838 |
32 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.76416787 |
33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.74975737 |
34 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.74020811 |
35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69534029 |
36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66659672 |
37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66577342 |
38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.65462435 |
39 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.64523890 |
40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63451409 |
41 | * MAF_26560356_Chip-Seq_TH2_Human | 1.62457203 |
42 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.62203189 |
43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59345069 |
44 | MAF_26560356_Chip-Seq_TH1_Human | 1.56974994 |
45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55836098 |
46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.54055936 |
47 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.53637573 |
48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52373124 |
49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49698897 |
50 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.49060955 |
51 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.48872345 |
52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46736311 |
53 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.41937177 |
54 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.41503193 |
55 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39623766 |
56 | MYC_22102868_ChIP-Seq_BL_Human | 1.36115763 |
57 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35801410 |
58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35422043 |
59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.34291358 |
60 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.32767655 |
61 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.32259618 |
62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32005832 |
63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30978957 |
64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30366524 |
65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.30059037 |
66 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.30004301 |
67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29139533 |
68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.28619996 |
69 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.27413762 |
70 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.26899500 |
71 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26779621 |
72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26701556 |
73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26323480 |
74 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.25659387 |
75 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25534310 |
76 | SA1_27219007_Chip-Seq_Bcells_Human | 1.25522984 |
77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.25362540 |
78 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25158487 |
79 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24864962 |
80 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.23191624 |
81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23099128 |
82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22924310 |
83 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.22650246 |
84 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.22552099 |
85 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.22209220 |
86 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21608531 |
87 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.21103419 |
88 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20891620 |
89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20793714 |
90 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20614471 |
91 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.20125373 |
92 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.19283190 |
93 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.17972971 |
94 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16860068 |
95 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.15516777 |
96 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15307292 |
97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14936853 |
98 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14352628 |
99 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.14299612 |
100 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.14108955 |
101 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13654416 |
102 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13654416 |
103 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.13618395 |
104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13606210 |
105 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12622379 |
106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11956933 |
107 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11768254 |
108 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.11610509 |
109 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.11148066 |
110 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.09703421 |
111 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.09512752 |
112 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08520844 |
113 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.07701166 |
114 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.06774816 |
115 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06554883 |
116 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05946907 |
117 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.05444472 |
118 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05241630 |
119 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05207407 |
120 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.05081201 |
121 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.05058895 |
122 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04807752 |
123 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.04215750 |
124 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04101783 |
125 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.03592808 |
126 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03443838 |
127 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.02731820 |
128 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02333251 |
129 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.02000988 |
130 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00605451 |
131 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99150094 |
132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98857852 |
133 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97938453 |
134 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.97894061 |
135 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.97521398 |
136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97198598 |
137 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.95400826 |
138 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.94716160 |
139 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94232332 |
140 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.93608636 |
141 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.90921652 |
142 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90315727 |
143 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.90121226 |
144 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90070326 |
145 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89738364 |
146 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.89047685 |
147 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88703176 |
148 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87411920 |
149 | * MYB_26560356_Chip-Seq_TH1_Human | 0.85614128 |
150 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85519305 |
151 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85069367 |
152 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.84670225 |
153 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.84558802 |
154 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.83403287 |
155 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.83192365 |
156 | MYB_26560356_Chip-Seq_TH2_Human | 0.81415435 |
157 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.79787105 |
158 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.79698158 |
159 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.79033718 |
160 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.78665298 |
161 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.78621310 |
162 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.77577202 |
163 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.77046616 |
164 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76270482 |
165 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.75261325 |
166 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.74817469 |
167 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.74564439 |
168 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.74344509 |
169 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.74009010 |
170 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.73735600 |
171 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.73091292 |
172 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.72989224 |
173 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.72567472 |
174 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.72306532 |
175 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.72165537 |
176 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.72104480 |
177 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.71883305 |
178 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.71189733 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002254_reproductive_system_inflammat | 5.89319000 |
2 | MP0006292_abnormal_olfactory_placode | 4.88114080 |
3 | MP0005394_taste/olfaction_phenotype | 4.52481787 |
4 | MP0005499_abnormal_olfactory_system | 4.52481787 |
5 | MP0003011_delayed_dark_adaptation | 3.83565175 |
6 | MP0005075_abnormal_melanosome_morpholog | 3.62307645 |
7 | MP0004264_abnormal_extraembryonic_tissu | 3.34842585 |
8 | MP0005058_abnormal_lysosome_morphology | 3.06821006 |
9 | MP0008260_abnormal_autophagy | 3.01384199 |
10 | MP0009278_abnormal_bone_marrow | 2.97546033 |
11 | MP0002822_catalepsy | 2.84252460 |
12 | MP0009840_abnormal_foam_cell | 2.67992688 |
13 | MP0006082_CNS_inflammation | 2.65029182 |
14 | MP0008789_abnormal_olfactory_epithelium | 2.60792706 |
15 | MP0003183_abnormal_peptide_metabolism | 2.56283503 |
16 | MP0000678_abnormal_parathyroid_gland | 2.43310769 |
17 | MP0004858_abnormal_nervous_system | 2.37811290 |
18 | MP0005451_abnormal_body_composition | 2.35294862 |
19 | MP0002277_abnormal_respiratory_mucosa | 2.34320238 |
20 | MP0003191_abnormal_cellular_cholesterol | 2.31086352 |
21 | MP0000465_gastrointestinal_hemorrhage | 2.20421237 |
22 | MP0003303_peritoneal_inflammation | 2.19852788 |
23 | MP0005310_abnormal_salivary_gland | 2.13489573 |
24 | MP0005387_immune_system_phenotype | 2.11347157 |
25 | MP0001790_abnormal_immune_system | 2.11347157 |
26 | MP0005671_abnormal_response_to | 2.04255621 |
27 | MP0008961_abnormal_basal_metabolism | 2.01222470 |
28 | MP0002249_abnormal_larynx_morphology | 1.98210819 |
29 | MP0004381_abnormal_hair_follicle | 1.97577267 |
30 | MP0004043_abnormal_pH_regulation | 1.94201503 |
31 | MP0001873_stomach_inflammation | 1.88788941 |
32 | MP0005257_abnormal_intraocular_pressure | 1.86224799 |
33 | MP0003329_amyloid_beta_deposits | 1.84477720 |
34 | MP0001984_abnormal_olfaction | 1.83677537 |
35 | MP0002332_abnormal_exercise_endurance | 1.81366966 |
36 | MP0005409_darkened_coat_color | 1.80029514 |
37 | MP0005397_hematopoietic_system_phenotyp | 1.79372604 |
38 | MP0001545_abnormal_hematopoietic_system | 1.79372604 |
39 | MP0002127_abnormal_cardiovascular_syste | 1.78534588 |
40 | MP0002796_impaired_skin_barrier | 1.77326241 |
41 | MP0003938_abnormal_ear_development | 1.75156328 |
42 | MP0003122_maternal_imprinting | 1.72624553 |
43 | MP0003866_abnormal_defecation | 1.72534951 |
44 | MP0004185_abnormal_adipocyte_glucose | 1.71113964 |
45 | MP0010155_abnormal_intestine_physiology | 1.67429856 |
46 | MP0005666_abnormal_adipose_tissue | 1.67229917 |
47 | MP0001800_abnormal_humoral_immune | 1.66705886 |
48 | MP0002396_abnormal_hematopoietic_system | 1.66378220 |
49 | MP0005360_urolithiasis | 1.65615848 |
50 | MP0003890_abnormal_embryonic-extraembry | 1.62871394 |
51 | MP0010234_abnormal_vibrissa_follicle | 1.56526380 |
52 | MP0003705_abnormal_hypodermis_morpholog | 1.53135790 |
53 | MP0003172_abnormal_lysosome_physiology | 1.50610185 |
54 | MP0003879_abnormal_hair_cell | 1.46130336 |
55 | MP0005464_abnormal_platelet_physiology | 1.44971068 |
56 | MP0008569_lethality_at_weaning | 1.42065920 |
57 | MP0009333_abnormal_splenocyte_physiolog | 1.41164431 |
58 | MP0002233_abnormal_nose_morphology | 1.38581302 |
59 | MP0002132_abnormal_respiratory_system | 1.36861521 |
60 | MP0001835_abnormal_antigen_presentation | 1.36482244 |
61 | MP0000681_abnormal_thyroid_gland | 1.33188706 |
62 | MP0003635_abnormal_synaptic_transmissio | 1.33083041 |
63 | MP0005000_abnormal_immune_tolerance | 1.31398343 |
64 | MP0005501_abnormal_skin_physiology | 1.31143349 |
65 | MP0005375_adipose_tissue_phenotype | 1.30622754 |
66 | MP0005551_abnormal_eye_electrophysiolog | 1.29598781 |
67 | MP0003690_abnormal_glial_cell | 1.29303084 |
68 | MP0001486_abnormal_startle_reflex | 1.29185548 |
69 | MP0002098_abnormal_vibrissa_morphology | 1.23806496 |
70 | MP0000003_abnormal_adipose_tissue | 1.23382888 |
71 | MP0003763_abnormal_thymus_physiology | 1.21389469 |
72 | MP0000604_amyloidosis | 1.18248298 |
73 | MP0000685_abnormal_immune_system | 1.16606448 |
74 | MP0006035_abnormal_mitochondrial_morpho | 1.16019959 |
75 | MP0005535_abnormal_body_temperature | 1.15960766 |
76 | MP0002723_abnormal_immune_serum | 1.15374896 |
77 | MP0003787_abnormal_imprinting | 1.13798133 |
78 | MP0005670_abnormal_white_adipose | 1.13304070 |
79 | MP0002420_abnormal_adaptive_immunity | 1.13056354 |
80 | MP0008057_abnormal_DNA_replication | 1.10245635 |
81 | MP0001819_abnormal_immune_cell | 1.08909378 |
82 | MP0000049_abnormal_middle_ear | 1.08546217 |
83 | MP0009379_abnormal_foot_pigmentation | 1.05911925 |
84 | MP0003828_pulmonary_edema | 1.05039859 |
85 | MP0002063_abnormal_learning/memory/cond | 1.04054874 |
86 | MP0000762_abnormal_tongue_morphology | 1.03638559 |
87 | MP0001664_abnormal_digestion | 1.01924738 |
88 | MP0002452_abnormal_antigen_presenting | 1.01069348 |
89 | MP0000490_abnormal_crypts_of | 1.01055238 |
90 | MP0001501_abnormal_sleep_pattern | 1.00259639 |
91 | MP0001188_hyperpigmentation | 0.99228140 |
92 | MP0000751_myopathy | 0.98777595 |
93 | MP0005253_abnormal_eye_physiology | 0.98136056 |
94 | MP0001502_abnormal_circadian_rhythm | 0.96198551 |
95 | MP0000716_abnormal_immune_system | 0.95886796 |
96 | MP0003453_abnormal_keratinocyte_physiol | 0.95418090 |
97 | MP0002572_abnormal_emotion/affect_behav | 0.95317476 |
98 | MP0001849_ear_inflammation | 0.93813372 |
99 | MP0003121_genomic_imprinting | 0.92637975 |
100 | MP0005423_abnormal_somatic_nervous | 0.91717959 |
101 | MP0002419_abnormal_innate_immunity | 0.91582370 |
102 | MP0003075_altered_response_to | 0.91554075 |
103 | MP0001348_abnormal_lacrimal_gland | 0.88902671 |
104 | MP0002653_abnormal_ependyma_morphology | 0.88529564 |
105 | MP0002405_respiratory_system_inflammati | 0.87358668 |
106 | MP0002398_abnormal_bone_marrow | 0.87194772 |
107 | MP0003123_paternal_imprinting | 0.86529056 |
108 | MP0002090_abnormal_vision | 0.86354839 |
109 | MP0002970_abnormal_white_adipose | 0.86030279 |
110 | MP0001324_abnormal_eye_pigmentation | 0.85906466 |
111 | MP0002722_abnormal_immune_system | 0.84642082 |
112 | MP0001765_abnormal_ion_homeostasis | 0.82916665 |
113 | MP0005025_abnormal_response_to | 0.82373395 |
114 | MP0000689_abnormal_spleen_morphology | 0.82017483 |
115 | MP0003880_abnormal_central_pattern | 0.80962443 |
116 | MP0005166_decreased_susceptibility_to | 0.79024178 |
117 | MP0000955_abnormal_spinal_cord | 0.78172350 |
118 | MP0000013_abnormal_adipose_tissue | 0.78156483 |
119 | MP0005391_vision/eye_phenotype | 0.76393008 |
120 | MP0000920_abnormal_myelination | 0.76305014 |
121 | MP0000858_altered_metastatic_potential | 0.75476405 |
122 | MP0002932_abnormal_joint_morphology | 0.75172709 |
123 | MP0000477_abnormal_intestine_morphology | 0.73533815 |
124 | MP0006036_abnormal_mitochondrial_physio | 0.72726726 |
125 | MP0008770_decreased_survivor_rate | 0.72640264 |
126 | MP0003436_decreased_susceptibility_to | 0.71966935 |
127 | MP0003634_abnormal_glial_cell | 0.71625491 |
128 | MP0000703_abnormal_thymus_morphology | 0.71445783 |
129 | MP0002429_abnormal_blood_cell | 0.70663881 |
130 | MP0004859_abnormal_synaptic_plasticity | 0.70593347 |
131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.70290898 |
132 | MP0001663_abnormal_digestive_system | 0.70108673 |
133 | MP0009931_abnormal_skin_appearance | 0.69425168 |
134 | MP0010368_abnormal_lymphatic_system | 0.69386173 |
135 | MP0002272_abnormal_nervous_system | 0.69204092 |
136 | MP0004142_abnormal_muscle_tone | 0.69137778 |
137 | MP0009785_altered_susceptibility_to | 0.68502420 |
138 | MP0003950_abnormal_plasma_membrane | 0.67219595 |
139 | MP0008874_decreased_physiological_sensi | 0.66497639 |
140 | MP0000747_muscle_weakness | 0.66341278 |
141 | MP0002752_abnormal_somatic_nervous | 0.65332646 |
142 | MP0000383_abnormal_hair_follicle | 0.65295400 |
143 | MP0002092_abnormal_eye_morphology | 0.64747283 |
144 | MP0004947_skin_inflammation | 0.64551812 |
145 | MP0004085_abnormal_heartbeat | 0.64497611 |
146 | MP0001293_anophthalmia | 0.63934209 |
147 | MP0002064_seizures | 0.63790492 |
148 | MP0003045_fibrosis | 0.61455432 |
149 | MP0000749_muscle_degeneration | 0.59647775 |
150 | MP0004270_analgesia | 0.59305181 |
151 | MP0002751_abnormal_autonomic_nervous | 0.59074787 |
152 | MP0005195_abnormal_posterior_eye | 0.58706986 |
153 | MP0008872_abnormal_physiological_respon | 0.58685690 |
154 | MP0001970_abnormal_pain_threshold | 0.57371698 |
155 | MP0002148_abnormal_hypersensitivity_rea | 0.56608404 |
156 | MP0000631_abnormal_neuroendocrine_gland | 0.55069878 |
157 | MP0000377_abnormal_hair_follicle | 0.54302715 |
158 | MP0002735_abnormal_chemical_nociception | 0.52211727 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Bilateral microphthalmos (HP:0007633) | 6.89291111 |
2 | Hypochromic microcytic anemia (HP:0004840) | 5.17648022 |
3 | Hepatoblastoma (HP:0002884) | 4.57078988 |
4 | Ankle clonus (HP:0011448) | 4.04481303 |
5 | Rib fusion (HP:0000902) | 4.04350617 |
6 | J-shaped sella turcica (HP:0002680) | 4.03381666 |
7 | Abnormality of the lower motor neuron (HP:0002366) | 3.82307943 |
8 | Cheilitis (HP:0100825) | 3.73835822 |
9 | Obstructive sleep apnea (HP:0002870) | 3.61215736 |
10 | Hypoplasia of the fovea (HP:0007750) | 3.60759879 |
11 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.60759879 |
12 | Supranuclear gaze palsy (HP:0000605) | 3.52514642 |
13 | Febrile seizures (HP:0002373) | 3.45852094 |
14 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.39682432 |
15 | Increased IgE level (HP:0003212) | 3.25119935 |
16 | Periauricular skin pits (HP:0100277) | 3.09161344 |
17 | Preauricular pit (HP:0004467) | 3.09161344 |
18 | Petechiae (HP:0000967) | 3.08993279 |
19 | Anomalous pulmonary venous return (HP:0010772) | 3.06537368 |
20 | Bifid tongue (HP:0010297) | 3.05718134 |
21 | Combined immunodeficiency (HP:0005387) | 3.05025295 |
22 | Lip pit (HP:0100267) | 3.01638693 |
23 | Epileptic encephalopathy (HP:0200134) | 2.99268266 |
24 | Hyperventilation (HP:0002883) | 2.97942633 |
25 | Multiple enchondromatosis (HP:0005701) | 2.97067668 |
26 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.95529791 |
27 | Eczematoid dermatitis (HP:0000976) | 2.95380087 |
28 | Partial duplication of thumb phalanx (HP:0009944) | 2.91047070 |
29 | Thin bony cortex (HP:0002753) | 2.90596499 |
30 | Myokymia (HP:0002411) | 2.89709314 |
31 | Nasolacrimal duct obstruction (HP:0000579) | 2.88267966 |
32 | Exercise-induced myalgia (HP:0003738) | 2.86431791 |
33 | Neuronal loss in central nervous system (HP:0002529) | 2.86413358 |
34 | Abnormality of the fovea (HP:0000493) | 2.85420697 |
35 | Neoplasm of striated muscle (HP:0009728) | 2.84489338 |
36 | Ependymoma (HP:0002888) | 2.82172139 |
37 | Intestinal fistula (HP:0100819) | 2.80173187 |
38 | Generalized hypotonia (HP:0001290) | 2.71971687 |
39 | Seborrheic dermatitis (HP:0001051) | 2.71519863 |
40 | Abnormality of the salivary glands (HP:0010286) | 2.71351840 |
41 | Reduced antithrombin III activity (HP:0001976) | 2.70102025 |
42 | Sensory axonal neuropathy (HP:0003390) | 2.68460049 |
43 | Myopathic facies (HP:0002058) | 2.67604936 |
44 | Visual hallucinations (HP:0002367) | 2.66293622 |
45 | Nasal polyposis (HP:0100582) | 2.62597095 |
46 | Neoplasm of the heart (HP:0100544) | 2.60433024 |
47 | Colitis (HP:0002583) | 2.60296645 |
48 | Reticulocytosis (HP:0001923) | 2.59651950 |
49 | Stridor (HP:0010307) | 2.59154749 |
50 | Dysostosis multiplex (HP:0000943) | 2.58183944 |
51 | Pendular nystagmus (HP:0012043) | 2.55489129 |
52 | Gastrointestinal inflammation (HP:0004386) | 2.49861340 |
53 | Increased cerebral lipofuscin (HP:0011813) | 2.48417290 |
54 | Abnormality of the pulmonary veins (HP:0011718) | 2.47717856 |
55 | Hemorrhage of the eye (HP:0011885) | 2.46686000 |
56 | Annular pancreas (HP:0001734) | 2.46416941 |
57 | Cellulitis (HP:0100658) | 2.45485335 |
58 | Distal lower limb amyotrophy (HP:0008944) | 2.44154011 |
59 | Broad face (HP:0000283) | 2.43543134 |
60 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.42961293 |
61 | Rectal fistula (HP:0100590) | 2.42865446 |
62 | Rectovaginal fistula (HP:0000143) | 2.42865446 |
63 | Amblyopia (HP:0000646) | 2.40245281 |
64 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.39602500 |
65 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.38898413 |
66 | Upper limb muscle weakness (HP:0003484) | 2.38528196 |
67 | Papilledema (HP:0001085) | 2.38465204 |
68 | Peripheral hypomyelination (HP:0007182) | 2.37961348 |
69 | Partial duplication of the phalanx of hand (HP:0009999) | 2.37201278 |
70 | Spinal canal stenosis (HP:0003416) | 2.36912174 |
71 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35246592 |
72 | Amyotrophic lateral sclerosis (HP:0007354) | 2.35123526 |
73 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.34502540 |
74 | Skin pits (HP:0100276) | 2.34201072 |
75 | Fatigue (HP:0012378) | 2.33841456 |
76 | Prolonged bleeding time (HP:0003010) | 2.32580178 |
77 | Growth hormone excess (HP:0000845) | 2.32213787 |
78 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.32033337 |
79 | Villous atrophy (HP:0011473) | 2.32033337 |
80 | Deformed sella turcica (HP:0002681) | 2.31375787 |
81 | Abnormality of the lacrimal duct (HP:0011481) | 2.31302701 |
82 | Neurofibrillary tangles (HP:0002185) | 2.31264943 |
83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30229865 |
84 | Horizontal nystagmus (HP:0000666) | 2.26342530 |
85 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25377565 |
86 | Preauricular skin tag (HP:0000384) | 2.24131347 |
87 | Easy fatigability (HP:0003388) | 2.23938595 |
88 | Malnutrition (HP:0004395) | 2.23069077 |
89 | Difficulty climbing stairs (HP:0003551) | 2.23012306 |
90 | Ragged-red muscle fibers (HP:0003200) | 2.22666690 |
91 | Cerebral palsy (HP:0100021) | 2.22601246 |
92 | Rhabdomyosarcoma (HP:0002859) | 2.20977993 |
93 | Slow saccadic eye movements (HP:0000514) | 2.19868001 |
94 | Hemiparesis (HP:0001269) | 2.19727549 |
95 | Hypertensive crisis (HP:0100735) | 2.18112617 |
96 | Congenital stationary night blindness (HP:0007642) | 2.16823894 |
97 | Cerebral inclusion bodies (HP:0100314) | 2.15240205 |
98 | Testicular atrophy (HP:0000029) | 2.14049304 |
99 | Difficulty walking (HP:0002355) | 2.13038483 |
100 | Thoracic kyphosis (HP:0002942) | 2.12157092 |
101 | Hyperthyroidism (HP:0000836) | 2.11814866 |
102 | Distal upper limb amyotrophy (HP:0007149) | 2.10829689 |
103 | Upper limb amyotrophy (HP:0009129) | 2.10829689 |
104 | Mucopolysacchariduria (HP:0008155) | 2.10788157 |
105 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10788157 |
106 | Agammaglobulinemia (HP:0004432) | 2.10391741 |
107 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.09783633 |
108 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.09783633 |
109 | Abnormality of glycolipid metabolism (HP:0010969) | 2.09783633 |
110 | Inflammation of the large intestine (HP:0002037) | 2.08871327 |
111 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.08104987 |
112 | Vaginal fistula (HP:0004320) | 2.07818500 |
113 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.07418505 |
114 | Systemic lupus erythematosus (HP:0002725) | 2.07119246 |
115 | Purpura (HP:0000979) | 2.05931391 |
116 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05555772 |
117 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05555772 |
118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05555772 |
119 | Increased IgM level (HP:0003496) | 2.04368798 |
120 | Obstructive lung disease (HP:0006536) | 2.03950224 |
121 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03950224 |
122 | Skin tags (HP:0010609) | 2.03627302 |
123 | Embryonal renal neoplasm (HP:0011794) | 2.03138532 |
124 | Large earlobe (HP:0009748) | 2.02967230 |
125 | Abnormality of the nasal mucosa (HP:0000433) | 2.02095868 |
126 | Abnormality of the thoracic spine (HP:0100711) | 2.01641994 |
127 | Truncus arteriosus (HP:0001660) | 2.00553913 |
128 | Gait imbalance (HP:0002141) | 1.99457876 |
129 | Restrictive lung disease (HP:0002091) | 1.98357605 |
130 | Loss of speech (HP:0002371) | 1.98054481 |
131 | Rapidly progressive (HP:0003678) | 1.97894393 |
132 | Hyperacusis (HP:0010780) | 1.97794434 |
133 | Congenital primary aphakia (HP:0007707) | 1.96293714 |
134 | Upper motor neuron abnormality (HP:0002127) | 1.95473706 |
135 | Tetraplegia (HP:0002445) | 1.95062589 |
136 | Tented upper lip vermilion (HP:0010804) | 1.93820868 |
137 | Chest pain (HP:0100749) | 1.92994202 |
138 | Neonatal onset (HP:0003623) | 1.91568933 |
139 | Spastic gait (HP:0002064) | 1.91563740 |
140 | Supernumerary nipples (HP:0002558) | 1.90382306 |
141 | Muscle stiffness (HP:0003552) | 1.89738241 |
142 | Abnormality of the astrocytes (HP:0100707) | 1.89476280 |
143 | Astrocytoma (HP:0009592) | 1.89476280 |
144 | Abnormality of the nasolacrimal system (HP:0000614) | 1.89476217 |
145 | Bulbar palsy (HP:0001283) | 1.89004910 |
146 | Dyschromatopsia (HP:0007641) | 1.88848464 |
147 | Abnormality of the pubic bones (HP:0003172) | 1.88721799 |
148 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87876164 |
149 | Foot dorsiflexor weakness (HP:0009027) | 1.87013900 |
150 | Cerebral aneurysm (HP:0004944) | 1.86115816 |
151 | Broad foot (HP:0001769) | 1.85737161 |
152 | Gastrointestinal dysmotility (HP:0002579) | 1.85427671 |
153 | Distal lower limb muscle weakness (HP:0009053) | 1.84609333 |
154 | Bifid scrotum (HP:0000048) | 1.84464891 |
155 | Axonal loss (HP:0003447) | 1.83103359 |
156 | Pulmonary infiltrates (HP:0002113) | 1.82604088 |
157 | Atelectasis (HP:0100750) | 1.82410076 |
158 | 3-Methylglutaconic aciduria (HP:0003535) | 1.81440169 |
159 | Protruding tongue (HP:0010808) | 1.80915226 |
160 | Spastic tetraparesis (HP:0001285) | 1.80576204 |
161 | Neurodegeneration (HP:0002180) | 1.80304545 |
162 | Hyperparathyroidism (HP:0000843) | 1.79867614 |
163 | Germ cell neoplasia (HP:0100728) | 1.79671984 |
164 | Gingivitis (HP:0000230) | 1.79516490 |
165 | Curly hair (HP:0002212) | 1.77847695 |
166 | Open mouth (HP:0000194) | 1.77622107 |
167 | Pili torti (HP:0003777) | 1.76177482 |
168 | Diminished motivation (HP:0000745) | 1.76176601 |
169 | Personality changes (HP:0000751) | 1.75477913 |
170 | Scrotal hypoplasia (HP:0000046) | 1.75367833 |
171 | Osteomalacia (HP:0002749) | 1.75015693 |
172 | Bowel incontinence (HP:0002607) | 1.74464092 |
173 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73681840 |
174 | Vasculitis (HP:0002633) | 1.73424767 |
175 | Hypochromic anemia (HP:0001931) | 1.73069215 |
176 | Dementia (HP:0000726) | 1.73039764 |
177 | Broad distal phalanx of finger (HP:0009836) | 1.72670602 |
178 | Recurrent abscess formation (HP:0002722) | 1.72622207 |
179 | Cholecystitis (HP:0001082) | 1.72492265 |
180 | Abnormal gallbladder physiology (HP:0012438) | 1.72492265 |
181 | Abnormality of the musculature of the hand (HP:0001421) | 1.72434912 |
182 | Type I transferrin isoform profile (HP:0003642) | 1.71840082 |
183 | Achilles tendon contracture (HP:0001771) | 1.71436537 |
184 | Lymphangioma (HP:0100764) | 1.71146657 |
185 | Trismus (HP:0000211) | 1.71136989 |
186 | Fused cervical vertebrae (HP:0002949) | 1.70976670 |
187 | Abnormal hair laboratory examination (HP:0003328) | 1.70533196 |
188 | Hypercortisolism (HP:0001578) | 1.70513765 |
189 | Recurrent fungal infections (HP:0002841) | 1.69249290 |
190 | Interstitial pulmonary disease (HP:0006530) | 1.68989506 |
191 | Panhypogammaglobulinemia (HP:0003139) | 1.68743427 |
192 | Lower limb amyotrophy (HP:0007210) | 1.68172466 |
193 | Abnormality of the fingertips (HP:0001211) | 1.67559171 |
194 | Recurrent sinusitis (HP:0011108) | 1.67553985 |
195 | Meningitis (HP:0001287) | 1.66811761 |
196 | Chromsome breakage (HP:0040012) | 1.66681041 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 6.28704138 |
2 | TRIB3 | 4.57897133 |
3 | GRK5 | 4.34930339 |
4 | ERN1 | 4.24342675 |
5 | GRK6 | 3.98819307 |
6 | ADRBK2 | 3.36076222 |
7 | CSF1R | 2.93116918 |
8 | TGFBR2 | 2.83128256 |
9 | GRK1 | 2.72995891 |
10 | MAPK7 | 2.50413916 |
11 | SIK2 | 2.45213623 |
12 | GRK7 | 2.39640669 |
13 | WNK1 | 2.31971675 |
14 | MAP3K11 | 2.21305495 |
15 | EEF2K | 2.13017877 |
16 | TYRO3 | 2.12985824 |
17 | STK10 | 1.99646815 |
18 | SMG1 | 1.89798746 |
19 | MARK2 | 1.81482771 |
20 | MAP2K3 | 1.81152570 |
21 | MATK | 1.79624299 |
22 | SIK3 | 1.79280888 |
23 | TESK2 | 1.75871144 |
24 | CAMKK1 | 1.71795451 |
25 | PKN2 | 1.69724795 |
26 | TESK1 | 1.65484219 |
27 | NME2 | 1.63851637 |
28 | ITK | 1.62400664 |
29 | PRKD3 | 1.58568515 |
30 | HIPK2 | 1.52972429 |
31 | IRAK3 | 1.43226706 |
32 | CAMK4 | 1.43172315 |
33 | MAP4K1 | 1.41684292 |
34 | SIK1 | 1.29981913 |
35 | CSK | 1.29147202 |
36 | SCYL2 | 1.24778204 |
37 | MOS | 1.24663908 |
38 | KDR | 1.23652246 |
39 | MAP3K1 | 1.20471841 |
40 | TAOK1 | 1.20397595 |
41 | RIPK4 | 1.20252118 |
42 | TBK1 | 1.19093910 |
43 | MAP3K7 | 1.17127582 |
44 | INSRR | 1.17053693 |
45 | ICK | 1.16554347 |
46 | TXK | 1.14767143 |
47 | NTRK1 | 1.13692901 |
48 | FGFR3 | 1.02371360 |
49 | MAPK12 | 1.01577938 |
50 | MAP3K14 | 1.01238896 |
51 | MAP3K6 | 1.00245549 |
52 | PDPK1 | 0.98007726 |
53 | PRKG2 | 0.95634282 |
54 | ADRBK1 | 0.92421343 |
55 | RPS6KA2 | 0.92188612 |
56 | ARAF | 0.91212880 |
57 | MAP2K6 | 0.89037181 |
58 | PTK6 | 0.88640815 |
59 | MAP2K2 | 0.88320425 |
60 | KIT | 0.88201854 |
61 | MUSK | 0.87678712 |
62 | MAP3K13 | 0.85765558 |
63 | DAPK1 | 0.84580910 |
64 | PDK1 | 0.84493220 |
65 | MAPK11 | 0.83885345 |
66 | BLK | 0.81053033 |
67 | BMX | 0.80686650 |
68 | PIM2 | 0.80404547 |
69 | KSR2 | 0.79981143 |
70 | UHMK1 | 0.77526971 |
71 | SYK | 0.76860419 |
72 | MST1R | 0.76577893 |
73 | MST4 | 0.75791119 |
74 | PAK6 | 0.75135046 |
75 | PRKD2 | 0.75079979 |
76 | LCK | 0.74070610 |
77 | IKBKB | 0.73242673 |
78 | HCK | 0.72196840 |
79 | PRKCQ | 0.69859293 |
80 | TNIK | 0.69278080 |
81 | LRRK2 | 0.67401130 |
82 | RPS6KC1 | 0.66823635 |
83 | RPS6KL1 | 0.66823635 |
84 | TAOK2 | 0.66455728 |
85 | PRPF4B | 0.66246917 |
86 | EIF2AK2 | 0.66046409 |
87 | CDC42BPA | 0.65958770 |
88 | MAP3K3 | 0.60812908 |
89 | AKT2 | 0.60069202 |
90 | MAP3K10 | 0.59969814 |
91 | CDK19 | 0.59394271 |
92 | MAPKAPK3 | 0.58727742 |
93 | PRKCH | 0.58460662 |
94 | RET | 0.58340885 |
95 | IGF1R | 0.57668866 |
96 | YES1 | 0.57610587 |
97 | EPHA4 | 0.57227533 |
98 | IRAK2 | 0.55591691 |
99 | TNK2 | 0.55001922 |
100 | JAK3 | 0.53784187 |
101 | NTRK2 | 0.52438771 |
102 | JAK1 | 0.51669326 |
103 | DYRK1A | 0.50477703 |
104 | INSR | 0.50241365 |
105 | CAMK1 | 0.50157663 |
106 | NEK6 | 0.50060020 |
107 | TTK | 0.49075213 |
108 | MTOR | 0.48593398 |
109 | AKT3 | 0.48441093 |
110 | NTRK3 | 0.47831966 |
111 | TYK2 | 0.47643374 |
112 | RPS6KA6 | 0.47497253 |
113 | MAP2K4 | 0.45630491 |
114 | FES | 0.44276137 |
115 | MARK3 | 0.44143847 |
116 | PRKCI | 0.44015760 |
117 | PTK2 | 0.43522228 |
118 | ZAP70 | 0.43504036 |
119 | CDK7 | 0.43468538 |
120 | LYN | 0.41287891 |
121 | PRKD1 | 0.40544249 |
122 | IRAK4 | 0.40498914 |
123 | CDK4 | 0.39112836 |
124 | LMTK2 | 0.38985062 |
125 | JAK2 | 0.38918229 |
126 | BRD4 | 0.38606950 |
127 | CASK | 0.37012257 |
128 | PRKCD | 0.36749214 |
129 | IKBKE | 0.36207851 |
130 | MAPK4 | 0.36080461 |
131 | FYN | 0.34698720 |
132 | PKN1 | 0.34632440 |
133 | FGFR4 | 0.33133483 |
134 | FGR | 0.32365800 |
135 | EPHB1 | 0.30170413 |
136 | CHUK | 0.28840813 |
137 | DAPK2 | 0.28625012 |
138 | BTK | 0.28238175 |
139 | CHEK2 | 0.27304280 |
140 | ALK | 0.27109538 |
141 | RIPK1 | 0.26137126 |
142 | ABL1 | 0.24996947 |
143 | SRC | 0.24821585 |
144 | DYRK1B | 0.24705338 |
145 | PDGFRB | 0.24567917 |
146 | MAP3K2 | 0.24511563 |
147 | CDK5 | 0.22586910 |
148 | MAPK10 | 0.22165410 |
149 | PRKACA | 0.21895395 |
150 | CSNK1A1 | 0.20561409 |
151 | STK38 | 0.20117697 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.43067303 |
2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.41989087 |
3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.87307275 |
4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.84144527 |
5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.35149633 |
6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.11025743 |
7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.89732233 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82854025 |
9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.82066988 |
10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80997175 |
11 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.72345291 |
12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70786928 |
13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.66223822 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65430867 |
15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59969283 |
16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.58466470 |
17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.47520110 |
18 | Taste transduction_Homo sapiens_hsa04742 | 1.46828655 |
19 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.45127829 |
20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42658862 |
21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40931583 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38958394 |
23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.38501703 |
24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.36114167 |
25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.35876650 |
26 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.35362854 |
27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.35148728 |
28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.32874187 |
29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.32667715 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32238731 |
31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.31056960 |
32 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.30755699 |
33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29104706 |
34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27038087 |
35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22083656 |
36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21232879 |
37 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.20460550 |
38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18779701 |
39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14230375 |
40 | Morphine addiction_Homo sapiens_hsa05032 | 1.13457797 |
41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.12078486 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12070710 |
43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11596492 |
44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10489513 |
45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06133410 |
46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.05811364 |
47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04611303 |
48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02859939 |
49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.00659080 |
50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00412279 |
51 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.98492258 |
52 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.97843381 |
53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.96270608 |
54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95760349 |
55 | Endocytosis_Homo sapiens_hsa04144 | 0.95752410 |
56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95628514 |
57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95605472 |
58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95577234 |
59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.95509639 |
60 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94292789 |
61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.93916429 |
62 | Glioma_Homo sapiens_hsa05214 | 0.93865892 |
63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92775360 |
64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91352222 |
65 | Lysosome_Homo sapiens_hsa04142 | 0.90873391 |
66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90627096 |
67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89602961 |
68 | Platelet activation_Homo sapiens_hsa04611 | 0.88059841 |
69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85964848 |
70 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.85936219 |
71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84377875 |
72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83975951 |
73 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83743618 |
74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83533279 |
75 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82768652 |
76 | ABC transporters_Homo sapiens_hsa02010 | 0.79764668 |
77 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79286546 |
78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78753820 |
79 | Tuberculosis_Homo sapiens_hsa05152 | 0.78688188 |
80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78267874 |
81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76155614 |
82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.75290242 |
83 | Prion diseases_Homo sapiens_hsa05020 | 0.74932269 |
84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73792764 |
85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73646853 |
86 | Insulin resistance_Homo sapiens_hsa04931 | 0.73425226 |
87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72429860 |
88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72155792 |
89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.72044977 |
90 | Phototransduction_Homo sapiens_hsa04744 | 0.71530109 |
91 | Circadian entrainment_Homo sapiens_hsa04713 | 0.71361611 |
92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70656178 |
93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69788360 |
94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69672213 |
95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69318493 |
96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.68934205 |
97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68076457 |
98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68067921 |
99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67069401 |
100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66579721 |
101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66293789 |
102 | Axon guidance_Homo sapiens_hsa04360 | 0.66209449 |
103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65751972 |
104 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65365913 |
105 | Bile secretion_Homo sapiens_hsa04976 | 0.64792006 |
106 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64604497 |
107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64363811 |
108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64073095 |
109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62975375 |
110 | Renin secretion_Homo sapiens_hsa04924 | 0.62947009 |
111 | Long-term depression_Homo sapiens_hsa04730 | 0.62138554 |
112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61901544 |
113 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.61721115 |
114 | Measles_Homo sapiens_hsa05162 | 0.61597731 |
115 | Salivary secretion_Homo sapiens_hsa04970 | 0.61010266 |
116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60569141 |
117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60230842 |
118 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59057632 |
119 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.57621835 |
120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57590472 |
121 | Insulin secretion_Homo sapiens_hsa04911 | 0.56993592 |
122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56258338 |
123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55861425 |
124 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55426289 |
125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55286076 |
126 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55095105 |
127 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55023493 |
128 | Base excision repair_Homo sapiens_hsa03410 | 0.54802061 |
129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54252219 |
130 | Hepatitis B_Homo sapiens_hsa05161 | 0.53819971 |
131 | Bladder cancer_Homo sapiens_hsa05219 | 0.53654079 |
132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53547202 |
133 | Salmonella infection_Homo sapiens_hsa05132 | 0.53464558 |
134 | Lysine degradation_Homo sapiens_hsa00310 | 0.53030429 |
135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52852465 |
136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52560977 |
137 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52272288 |
138 | Hepatitis C_Homo sapiens_hsa05160 | 0.51746321 |
139 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51709738 |
140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50961949 |
141 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50472774 |
142 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50107046 |
143 | Apoptosis_Homo sapiens_hsa04210 | 0.49931994 |
144 | Allograft rejection_Homo sapiens_hsa05330 | 0.49908801 |
145 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47278122 |
146 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.44157212 |
147 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43655989 |
148 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43588752 |
149 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42185298 |
150 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41069797 |
151 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39907635 |
152 | Influenza A_Homo sapiens_hsa05164 | 0.39500785 |